Racial discrimination and adverse pregnancy outcomes: a systematic review and meta-analysis

KR van Daalen, J Kaiser, S Kebede, G Cipriano… - BMJ Global …, 2022 - gh.bmj.com
Introduction Racial discrimination has been consistently linked to various health outcomes
and health disparities, including studies associating racial discrimination with patterns of …

[HTML][HTML] A systematic review of the association between vegan diets and risk of cardiovascular disease

J Kaiser, KR van Daalen, A Thayyil, MTAR Reis… - The Journal of …, 2021 - Elsevier
Background Plant-based diets are gaining attention globally due to their environmental
benefits and perceived health-protective role. A vegan diet may have cardiovascular …

[HTML][HTML] The prognostic role of the change in neutrophil-to-lymphocyte ratio during neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a …

J Kaiser, H Li, SA North, R Leibowitz-Amit… - Bladder …, 2018 - content.iospress.com
Background: The impact of the change in the neutrophil-to-lymphocyte ratio (NLR) during
neoadjuvant chemotherapy (NAC) on outcomes in patients with muscle-invasive bladder …

The prognostic impact of bone metastasis in patients with metastatic urothelial carcinoma treated with first-line platinum-based chemotherapy

HA Alqaisi, C Stecca, ZW Veitch… - Therapeutic …, 2022 - journals.sagepub.com
Background: In metastatic urothelial cancer (mUC), bone metastasis (BM) are associated
with significant morbidity and mortality, yet their role as an independent prognostic variable …

Real-world outcomes in advanced urothelial cancer and the role of neutrophil to lymphocyte ratio

SM Yip, J Kaiser, H Li, S North, DYC Heng… - Clinical Genitourinary …, 2018 - Elsevier
Introduction In the first-and second-line metastatic urothelial carcinoma (mUC) treatment
setting, we investigated real-world outcomes and evaluated the prognostic role of neutrophil …

The prognostic impact of bone metastasis in urothelial carcinoma treated with first-line platinum-based chemotherapy.

H Alqaisi, ZWN Veitch, C Stecca, J Kaiser, SA North… - 2021 - ascopubs.org
415 Background: Metastatic urothelial carcinoma (mUC) is an aggressive disease with a
median overall survival (OS) of≈ 15 months. In the first-line setting, key prognostic factors …

Assessment of the alignment between research funding allocation and consensus research priority areas in kidney cancer.

S Lu, J Kaiser, MAS Jewett, DYC Heng… - 2021 - ascopubs.org
e16538 Background: Finite resources are available to fund research, and it is important to
ensure stakeholder input is identified and prioritized. In this light, the KCRNC and CIHR …

Trends over time in survival in patients with urothelial carcinoma in the real-world: A multicenter analysis.

S Samnani, ZWN Veitch, J Kaiser, C Stecca, H Alqaisi… - 2021 - ascopubs.org
412 Background: Patients with muscle-invasive bladder cancer (MIBC) historically have
poor long-term outcomes, with nearly 50% developing metastatic disease. Similarly, patients …

Bladder cancer research funding in Canada and the United States: A comparison between stakeholder priorities and resource allocation from 2017 to 2019.

J Kaiser, I Litt, AB Smith, B Bhindi, NS Alimohamed - 2021 - ascopubs.org
422 Background: There is an increasing emphasis on patient-centered research to
encourage cancer care that is responsive to patients' needs. Previously, the Bladder Cancer …

Baseline neutrophil to lymphocyte ratio as a prognostic marker for patients with muscle-invasive bladder cancer being treated with neoadjuvant chemotherapy.

J Kaiser, H Li, JA Seah, R Leibowitz-Amit, SA North… - 2016 - ascopubs.org
468 Background: The neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, has
been associated with a poor prognosis in several solid malignancies. In muscle-invasive …